Neomorph

(2)

Philip Chamberlain and the problem of people saying yes

Before Neomorph had a team, Philip Chamberlain worried that nobody would join. Then came the more interesting worry: what happens if they do?

philip-chamberlain · phil-chamberlainRead →

Legend

Founder · Scientist · Executive

Phil Chamberlain

Phil Chamberlain is the co-founder, president and CEO of Neomorph, a San Diego biotech building molecular glue degraders to drug proteins long written off as untouchable. An Oxford-trained structural biologist, he spent a decade at Celgene and Bristol Myers Squibb decoding how thalidomide works at the atomic level, then turned that science into a company that has signed partnerships with AbbVie, Biogen and Novo Nordisk worth billions and pushed its lead degrader into the clinic.

molecular-glue · targeted-protein-degradationRead →